Fisher & Paykel Healthcare renews key US distribution deal

Healthcare products maker Fisher & Paykel Healthcare (FPH) has renewed a key distribution deal that gets its products into US hospitals.

Renewal of a 25-year-old agreement continues to give global medical tech giant CareFusion exclusive distribution rights for FPH’s respiratory care products in US hospital market.

CareFusion will continue to be the US distributor of FPH’s portfolio of respiratory consumable products that help with the treatment of obstructive sleep apnea.

CareFusion has its own respiratory consumables business under the AirLife brand.

Shares in FPH last traded at $2.11, having fetched between $2.09 and $3.19 in the last year.

Got a question about this story? Leave it in Comments & Questions below.

This article is tagged with the following keywords. Find out more about MyNBR Tags

Comments & Questions

Commenter icon key: Subscriber Verified

Post New comment or question

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.